Abstract
ABSTRACTThe number of medicine stock-outs (MSOs) is increasing globally. In Mauritania, they are recurring, although, to our knowledge, no study has yet been conducted to determine the causes. Therefore, this qualitative study aims to identify the main local or national causes of stock-outs to provide a common understanding and guide policy-makers towards corrective actions. The study was carried out in five health districts and at the regional and central levels. The samples were purposive. Two focus groups and twenty semi-structured individual interviews were held with 38 participants, including health professionals, managers from the Central Purchasing Office for Essential Medicines and Consumables (CAMEC), the Pharmacy and Laboratory Department (DPL) and the Ministry of Health (MoH). All interviews were recorded and transcribed. A thematic content analysis was carried out. Our findings indicate the national causes of MSOs at three healthcare system levels (operational, regional, and central). They were grouped into five categories: insufficient human resource capacity (number of staff, training, retention), communication and coordination problems between stakeholders, logistical constraints (transport, storage), financial constraints, inadequate forecasting of needs, and complex procurement procedures. These causes of MSOs are interconnected, and many could be addressed locally through solutions initiated and led by the Mauritanian authorities. To address MSOs sustainably, we suggest and discuss some possible actions, including reforms to improve CAMEC’s governance and accountability and, more broadly, to strengthen the various pillars of the local health and pharmaceutical system.
Publisher
Cold Spring Harbor Laboratory
Reference66 articles.
1. World Health Organization International Health Conference, New York; 1946. https://www.who.int/about/who-we-are/constitution. Accessed: 20 February 2023
2. Chan M. Ten years in public health 2007-2017: report by dr margaret chan director-general world health organisation: World Health Organization; 2018.
3. WHO. Towards access 2030: WHO essential medicines and health products strategic framework 2016-2030. World Health Organization; 2017.
4. Medicines shortages
5. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis;The lancet,2009